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ABSTRACT 
Ayurveda classics mentioned various types of Swasa and Tamaka Swasa is one among them. 
Tamakaswasa is manifested by aggravated Pranavayu by the obstruction of Kapha. In this case 
treatment should be to clear out Pranavaha srotas, pacify Vata and remove the blockage due to 
Kapha. In modern science Tamaka Swasa is correlated with Bronchial Asthma. It’s a chronic 
inflammatory disorder of the airways in which the chronic inflammation causes an associated 
increase in airway hyper responsiveness that leads to recurrent episodes of asthmatic exacerbation. 
Modern science has no permanent cure of Tamaka Swasa, that’s why it is necessity to search herbal 
and herbo-mineral preparations for the treatment of disease. Present Study was conducted to 
reduce the symptoms of Tamakaswasa. Bharangyadi Choorna and Vyaghri Choorna have the 
properties of Kapha Vata hara, Agni Deepana, Pachana, Anulomana, Srotoshodhana, anti-asthamatic 
and anti-inflammatory property. Materials and Method: Patients who have symptoms of 
Tamakaswasa fulfill the inclusion criteria were given with Bharangyadi Choorna 4gm thrice a day 
along with Ardraka Swarasa as Anupana in the trail group i.e., group A and Vyaghri Choorna 4gm 
thrice a day along with honey as Anupana in the control group i.e. group B. It is a comparative 
clinical study with 30 patients in each group for 30 days. Analyzing the signs and symptoms, PEFR 
after each 10 days, Wilcoxon test was done for comparing the effectiveness of treatment between 
two groups. Comparative analysis of the overall effect of the treatments in both the groups was done 
by statistically done by Mann-Whitney test. Results: There was statistically significant change in all 
the signs and symptoms and PEFR after treatment and follow up. All the signs and symptoms have 
P≤0.05. Conclusion: Bharangyadi Choorna has shown highly significant reduction in the symptoms 
like Swasakrichratha, Peenasa, Kasa, Ghurghuraka, Krichrabhashana, Shushkasya and PEFR. On 
comparison between the two groups, Bharangyadi choorna showed a better result in improvement 
of symptoms- Swasakrichratha, Peenasa, Kasa, Ghurghuraka, Krichrabhashana, Shushkasya and 
objective parameter- PEFR. Hence H2 hold good. 
KEYWORDS: Tamaka Swasa, Bronchial Asthma, Bharangyadi Choorna, PEFR, Vyaghri Choorna. 
INTRODUCTION 
 Tamaka Swasa is mentioned as one of the 
variety among five types of Swasa. But out of these, 
Kshudra Swasa present as symptom in most of the 
diseases and both type of Swasa are manageable, 
whereas Maha Swasa, Urdhva Swasa and Chinna 
Swasa were present in the terminal stages of various 
diseases. Tamaka Swasa is a 'Swantartra' Vyadhi and 
having its own Nidana, Samprapthi and Chikista. 
Prana Vayu moves in the reverse order, pervades the 
Srotas, afflicts the Greeva and Shira, and stimulates 
Kapha to cause Pinasa resulting in Tamakaswasa. The 
main causative factors of Tamaka Swasa are Raja, 
Dhooma, Vata, Sheetha Sthana Nivasa, Sheethambu 
Sevana, Ativyayama and Rookshanna Sevana. It is 
mentioned as Yaapya Vyadhi i.e., chronic in nature. 
Bronchial asthma mentioned in Modern Medicine 
closely resembles with Tamaka Swasa. 
The process of breathing in and out is 
effortless, thus hardly noticeable, and therefore, often 
taken for granted for most of us. Through a life span, 
consider the newborn’s first gasp for air outside 
mother’s womb, signifying the wonderful act of entry 
into this world, the infant’s first vocal sounds and 
lisps that express emotions enabling communication 
with the world, and finally, the inevitable act of dying, 
or expiration, marked by giving the spirit away with 
the last breath- all tied to the respiratory tract. 
Asthma may be as a chronic inflammatory 
disorder of the airways in which many cells plays a 
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role in particular mast cells, eosinophils and T 
lymphocytes. In susceptible individuals this 
inflammation causes recurrent episodes of wheezing, 
breathlessness, Chest tightness and Cough 
particularly at night or in the early morning. These 
symptoms are usually associated with wide spread 
but variable air flow limitation that is at least partly 
reversible either spontaneously or with treatment. 
The inflammation also causes associated increase 
airway responsiveness to a variety of stimuli. 
Bronchial asthma is a respiratory disorder 
that has increased dramatically over the past two 
decades[1]. It is a frightening condition which can 
seriously impede one’s breathing ability, and 
suddenly rob the individual of the most important 
nutrient of all- oxygen. People who are having an 
Asthma attack have real trouble taking a breath. 
Asthma affects peoples of all age and can be severe, 
sometimes fatal. Over 100 million people worldwide 
have suffering from Asthma, the prevalence is 
increasing among children. As with all chronic 
diseases rising prevalence is only part of the concern. 
Mortality due to asthma rose in last decade and has 
not changed in recent years. Morbidity due to 
exacerbations and persistent symptoms present as a 
huge burden to individuals and their community.  
The prevalence of bronchial asthma is 
increasing alarmingly now a day due to increased air 
pollution, overcrowding, occupational conditions, 
stress and poor hygiene. As per WHO 2011 health 
reports, about 235 million people are suffering from 
bronchial asthma. The prevalence of asthma has risen 
in affluent countries over last 30 years but now 
appears stabilized with ~10-12% of adults and 15% 
of children affected by the disease[2]. It is estimated 
that there may be an additional 100 million people 
with asthma by 2025[3]. In India it is estimated 
around 15-20 million peoples are asthmatics and it 
was seen as one of the leading cause of morbidity and 
mortality in rural India.[4] 
In 2005 GINA Workshop explained, “The rate 
of asthma increases as communities adopt western 
lifestyles and become urbanized. With the projected 
increase in the proportion of the world's population 
that is urban from 45% to 59% in 2025, there is 
likely to be a marked increase in the number of 
asthmatics worldwide over the next two decades. It is 
estimated that there may be an additional 100 
million persons with asthma by 2025.” 
Bronchial Asthma can be related with 
Tamaka Swasa in Ayurveda which is mentioned as 
one of the variety among five types of Swasa. Acharya 
mentioned Shamana and Shodhana Chikitsa for 
Tamakaswasa in different contexts. Shodhana 
procedure has given a due importance in this disease 
by almost all Acharyas. Although Shodhana therapy 
shows better result than Shamana therapy and 
already many scholars have proved this but 
Shodhana therapy is not possible in all the conditions 
and in all the patients, all time and in the classics also, 
the Shamana therapy has been considered better 
than Shodhana and Bhramhana therapy (Ch.Chi 
17/149). Comparing Shodhana and Shamana Chikitsa, 
Shodhana even if considered superior to Shamana 
can be done only Dosha vitiation is more, need 
hospitalization and can be done only in good body 
strength person. 
The current management of Tamakaswasa 
(Bronchial asthma) by modern medicines provides 
only short term symptomatic relief but does not 
provide any long term relief to the patients. Shamana 
can be done in all age groups, even in patients of less 
body strength and can be done in O.P basis also. Here 
arises the need of an effective polyherbal 
combination which alleviate Kapha and Vata Dosha, 
having Agni Deepana, Anulomana, Srotosodhana and 
which can actively interfere in the disease pathology. 
This study has been designed to assess the 
effectiveness of Bharangyadi Choorna and Vyaghri 
Choorna in Tamaka Swasa (bronchial asthma). 
Bharangyadi Choorna[5] and Vyaghri Choorna[6] have 
the properties of Kapha Vatahara, Agnideepana 
Pachana, Anulomana, Srotoshodhana, anti-asthamatic 
and anti inflammatory property. The aim of the study 
is to assess clinically, the effectiveness of 
Bharangyadi Choorna and Vyaghri Choorna. 
MATERIALS AND METHODS 
Source of Data 
Literary source 
All the Ayurvedic classics, contemporary 
Ayurvedic literatures, modern texts and internet 
sources mentioning about the condition, medicine 
and administration were reviewed and documented 
for the intended study. 
Sample source 
Patients who fulfill the inclusion criteria will 
be randomly selected from OPD and IPD of Karnataka 
Ayurvedic Medical College Hospital, special camp 
conducted for the purpose and from referral sources. 
Pharmaceutical source 
Raw drugs will be procured from authentic 
sources in and around Mangalore and preparation of 
Choorna will be carried out at the teaching pharmacy 
attached to Karnataka Ayurveda medical college, 
Mangalore.  
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Method of Preparation of Drug 
Bharangyadi choorna 
• Bharangi 
• Shunti 
These two drugs are taken equal quantity should be 
powdered, sieved to form Sookshma choorna and it 
will be preserved in an air tight container.  
Anupana: Ardraka swarasa 
Vyaghri choorna 
• Vyaghri 
• Jeeraka 
• Dhatri 
All these drugs taken in equal parts should be 
powdered together and sieved to form Sookshma 
Choorna and it will be preserved in an air tight 
container.  
Anupana: Madhu 
Method of Collection of Data 
a. Sample size: A minimum of 60 patients fulfilling 
the diagnostic and inclusion criteria of either 
gender were selected for the clinical study. They 
were randomly assigned into two groups A and B 
with 30 patients each. 
b. Diagnostic Criteria: Diagnosis will be made on 
the basis of Lakshanas of Tamaka Swasa like 
i. Swasakrichrata (difficulty in breathing) 
ii. Peenasa (rhinitis) 
iii. Kasa (cough) 
iv. Ghurghuraka (wheezing) 
v. Shushkasya (dryness in the mouth) 
vi. Krichrabhashana (difficulty in speaking) and  
Symptoms of Bronchial asthma like wheezing, 
breathlessness, chest tightness and coughing will be 
included in this study.  
c. Inclusion criteria 
i. Patients having classical signs and symptoms 
of Tamaka Swasa and Bronchial Asthma of 
mild to moderate nature.  
ii. Age group between 16 to 60 years of either 
gender. 
iii. Patient not taking any other medications for 
Tamakaswasa. 
iv. PEFR 60% - 90% 
v. Conscious and well oriented 
d. Exclusion criteria 
i. Asadhya Lakshanas of Tamaka Swasa 
ii. The patient with history of Tuberculosis, 
Emphysema, Pulmonary effusion, COPD, 
Other complicated respiratory diseases 
having any organic lesion such as tumor or 
any anatomical defect in airway. 
iii. Pregnant and lactating women. 
iv. Uncontrolled Hypertension, Diabetes mellitus 
e. Investigations 
Following lab investigations will be performed for 
the diagnosis and to rule out major pathological 
conditions: 
 Peak Flow Meter Reading 
 Spirometry (if needed) 
 Blood Routine: Hb gm%, TC, DC, ESR 
 Radiological - Chest X – ray P/A view (if 
necessary) 
 Absolute Eosinophil Count 
Procedure and design of the study 
A comparative clinical study with pre-test and 
post-test design will be conducted on 60 patients 
divided into two groups. i.e., Group A and Group B, 
each comprising 30 patients. 
Intervention: 
Table 1: Bharangyadichoorna Group A 
Sample size 30 
Drug Bharangyadichoorna 
Dose  4gm Choorna with Ardraka Swarasa thrice in a day after 
food. 
Table 2: Vyaghri Choorna Group B 
Sample size 30 
Drug Vyaghri Choorna 
Dose  4gm Choorna with Madhu thrice in a day after food  
Follow up period: 10th day after stoppage of medications. 
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Assessment criteria 
Table 3: Grading of Symptoms 
S. no Assessment 
criteria 
0 (Normal) 1 (mild) 2 (moderate) 3 (severe) 
1  Swasakrichratha No dyspnoea Occasional or 
morning bouts- 
do not disturb 
work 
Continuous 
during morning-
disturbing work 
Continuous during 
morning and night, 
disturbing activity 
2  Ghurkuraka No wheeze Wheezing at end 
of respiration 
Loud wheezing 
throughout 
expiration 
Loud inspiration and 
expiration wheeze 
3  Krichrabhashana Not at all Hardly any of the 
time 
Moderate 
amount of time 
Most of the time 
4  Kasa No cough Occasional or 
Morning bouts- 
do not disturb 
work  
Continuous 
cough during 
morning- 
disturbing work 
Continuous morning 
and night cough–
disturbs activity  
5  Shushkasya No dryness of 
mouth 
Mild moderate Severe 
6  Pinasa No symptom Initially present 
or occasionally 
Continuous in 
day with cough 
Continuous in day 
and night with cough 
7  PEFR >80% of the 
predicted value 
70-80% of the 
predicted value 
61-70% of the 
predicted value 
≤60% of the 
predicted value 
Statistical Analysis 
 Statistical analysis will be done using SPSS 
package, version 22. 
 All the qualitative variables are summarized 
using frequency and percentage. 
 The quantitative variables are summarized using 
mean and standard deviation, median and 
interquartile range (Q3, Q1). 
 Data needs to be analyzed using normal 
distribution then performing parametric and 
non parametric tests. 
 Since all subjective variables are qualitative 
data, assessment will be done by Wilcoxon sign 
test and Mann- Whitney test.  
OBSERVATIONS AND RESULTS 
Higher incidence of Tamakashwasa was 
reported in age Group 38-47 years. They were 30% 
and 26.7% respectively in A and B Group. Out of 60 
patients in group A and Group B, 27 patients were 
female and 33 patients were male. Out of total 60 
patients in Group A and Group B, maximum patients 
were found moderate Nature of Work. They were 31 
(51.7%). Out of total 60 patients in group A and 
Group B, maximum patients were of Hindu religion 
(55%). Out of total 60 patients in group A and Group 
B, maximum patients occupation are Housewife 
(16.67%). Out of total 60 patients in Group A and 
Group B, maximum patients’ Socio Economic Status 
were middle i.e, 32 (53.3%). Marital status: Out of 60 
patients 76.7% were married. That could be because 
of the inclusion of patients between age 16-60 years 
includes the maximum of marital age. In this study 
out of 60 patients, majority of patients had disturbed 
sleep 50%. Whereas 28.8%patients had irregular 
sleep, 13.3% patients had delayed sleep and 6.7% 
had sounded sleep. Out of total 60 patients in Group 
A and Group B, maximum patients pet keeping were 
no (81.7%). In Group A, they were 80% and in Group 
B they were 83.3%. Out of total 60 patients in Group 
A and Group B, maximum patients Habit were Nil 
(33.33%). Some patients had the habit of smoking 
beedi, cigarette and some are addicted to tea/ coffee 
and 5% are using snuff. Out of total 60 patients in 
Group A and Group B, maximum patients Diet were 
mixed (75%).Out of total 60 patients in Group A and 
Group B, maximum patients Chronicity were upto 1 
year (75%). Out of total 60 patients in Group A and 
Group B, maximum patients Education were High 
School (50%).  
RESULTS 
In this work of 30 patients studied in Tamaka 
swasa with Group-A 53.70% and 38.64% 
improvement seen in Swasakrichratha. An 
assessment of Peenasa in patients of Tamaka swasa 
before and after the treatment with Group-A showed 
84.21% and Group-B showed 58.82% improvement. 
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Magnitude of Kasa in patients of Tamakaswasa before 
and after the treatment in Group-A showed 69.70% 
improvement whereas in Group-B 47.52% 
improvement. Magnitude of Ghurghuraka in patients 
of Tamakaswasa in Group-A is 62.50 and in Group-B 
45.10% improvement. Magnitude of Krichra 
Bhashana in patients of Tamaka swasa In Group-A 
70.59% improvement and in Group-B 60% 
improvement. Magnitude of Shushkasya in patients of 
Tamakaswasa in Group-A 76% improvement. Further 
in Group-B 38.89% improvement. Magnitude of PEFR 
in patients of Tamakaswasa in Group-A had 92.41% 
improvement. Further in Group-B 27.08% 
improvement.  
Effects on Bharangyadi Choorna (Group A) 
Table 4: Subjective and Objective Parameter 
Effect on Vyaghri Choorna (Group B) 
Table 5: Subjective and Objective Parameter 
Symptoms 
Mean score 
% S.D (±) S.E (±) 
Wilxocon 
Z Value 
p value 
BT     BT-AT 
Swasakrichratha 1.80 
AT 1.10 0.70 38.89 0.651 0.121 3.72 <0.05 
AF 0.83 0.97 53.70 0.556 0.103 4.37 <0.05 
Peenasa 0.63 
AT 0.33 0.30 47.37 0.535 0.099 2.00 >0.05 
AF 0.10 0.53 84.21 0.629 0.117 2.20 <0.05 
Kasa 1.10 
AT 0.63 0.47 42.42 0.571 0.106 3.83 <0.05 
AF 0.33 0.77 69.70 0.728 0.135 4.70 <0.05 
Ghurghuraka 1.87 
AT 1.17 0.70 37.50 0.596 0.111 2.00 <0.05 
AF 0.70 1.17 62.50 0.461 0.086 3.05 <0.05 
Krichra Bhashana 0.57 
AT 0.44 0.13 23.53 0.346 0.064 3.05 <0.05 
AF 0.17 0.40 70.59 0.498 0.093 3.62 <0.05 
Shushkasya 0.83 
AT 0.36 0.47 56.00 0.629 0.117 4.70 <0.05 
AF 0.20 0.63 76.00 0.615 0.114 4.78 <0.05 
PEFR 1.60 
AT 1.40 0.20 12.50 0.407 0.076 2.20 <0.05 
AF 1.17 0.43 27.08 0.504 0.094 3.18 <0.05 
Symptoms 
Mean score % S.D (±) S.E (±) Wilxocon Z Value p value 
BT     BT-AT      
Swasakrichratha 1.47 
AT 1.17 0.30 20.45 0.466 0.087 2.66 <0.05 
AF 0.90 0.57 38.64 0.679 0.126 3.24 <0.05 
Peenasa 0.57 
AT 0.44 0.13 23.53 0.434 0.081 1.47 <0.05 
AF 0.24 0.33 58.82 0.479 0.089 2.80 <0.05 
Kasa 1.20 
AT 1.00 0.20 16.67 0.407 0.076 2.20 <0.05 
AF 0.63 0.57 47.22 0.626 0.116 3.40 <0.05 
Ghurghuraka 1.70 
AT 1.53 0.17 9.80 0.379 0.070 2.02 <0.05 
AF 0.93 0.77 45.10 0.430 0.080 4.19 <0.05 
Krichra Bhashana 0.83 
AT 0.63 0.20 24.00 0.407 0.076 2.20 <0.05 
AF 0.33 0.50 60.00 0.509 0.094 3.40 <0.05 
Shushkasya 0.60 
AT 0.33 0.27 44.44 0.521 0.097 2.36 <0.05 
AF 0.37 0.23 38.89 0.430 0.080 2.36 <0.05 
PEFR 1.60 
AT 1.40 0.20 12.50 0.407 0.076 2.20 <0.05 
AF 1.17 0.43 27.08 0.504 0.094 3.18 <0.05 
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Table 6: Comparative results of Group-A and Group-B 
Signs and 
Symptoms 
Group A 
(Mean Score) 
Group B 
(Mean Score) 
Z-Value of Mann 
Whitney 
U Value P Value 
Swasakrichratha 1.24 1.18 0.47 417.50 >0.05 
Peenasa 0.36 0.41 0.05 445.50 >0.05 
Kasa 0.69 0.94 1.47 349.50 >0.05 
Ghurghuraka 1.24 1.39 0.98 383.00 >0.05 
KrichraBhashana 0.39 0.60 1.75 330.50 >0.05 
Shushkasya 0.47 0.43 0.63 406.50 >0.05 
PEFR 1.28 1.39 0.03 447.00 >0.05 
Table 7: Overall Comparative Results of Group A and Group B 
Group A Group B Mean 
Difference 
SE (±)  Z-Value of 
Mann Whitney 
U Value P value 
75.64 46.23 29.41 5.99 4.63 136 <0.05 
Comparative analysis of the overall effect of 
the treatments in both the groups was done by 
statistically with Mann Whitney test. The test shows 
that the treatment is significant in Group A when 
compared to Group B. Group A overall result is 
75.64% and Group B overall result is 46.23%. 
DISCUSSION 
Tamakaswasa is manifested by the 
aggravated Pranavayu by the obstruction of Kapha. 
The symptoms of Tamakaswasa are Swasakrichratha, 
Muhurmuhur Swasa, Ghurghuraka, Kasa, Peenasa, 
Shayanasya, Swasapeeditha, Kaphanishtivam, 
Urahapeeda, Peenasa, Parshwashoola, Shushkasya etc. 
Attack of the disease cause entering of darkness due 
to vitiation of Vata which in turns vitiates Kapha and 
it obstructs the passage of Pranavata this produce the 
upward movement of Vata or abnormal dyspnoea. 
The whole Charaka Chikitsa Adhyaya 17 is 
dedicated to differentiate the Sadhya and Asadhya 
Swasa based on the symptomatology and then the 
treatment of Sadhya or Yapya variety of Swasa 
(Tamaka Swasa). From the treatment point of view, 
Tamaka Swasa has got a great importance due to its 
Sadhya (including Kriccha and Yapya) nature and 
being manageable. Swasa is being existed from the 
very primitive age as evident in Vedic literatures. 
References regarding Swasa in both physiological and 
pathological senses can be obtained from Vedic 
literature onwards. The importance of respiration in 
life sustenance has been ascertained by the usage of 
the word Prana Vayu for inhaled air. Puranas, 
Upanishads and Brahmanas also have given many 
references about Swasa Kriya and many a times 
about Swasa Roga as well. Description of Swasa Roga 
is available in Brihattrayee as well as Laghuttrayee. 
In the Tamakaswasa it is clearly explained 
about the types Swasa Roga and it is classified into 
five on the basis of severity. Kshudra Swasa can be 
seen as a symptom in many diseases and is self 
limiting. Chhinna, Urdhwa and Maha Swasa are the 
terminal stages and have extremely bad prognosis. 
Then explained about Nirukthi, Nidana, Puravarupa, 
Rupa, Samprapthi, Samprapthighataka, Upashay-
anupashaya, Vyadhivyavechedaka, Chikitsa and 
Pathyapathya. In modern view it is explained about 
Asthma which is a chronic inflammatory disorder of 
the respiratory airways, asthma is characterized by 
bronchial airway inflammation resulting in increased 
mucus production and airway hyper-responsiveness. 
The resultant symptomatology includes episodes of 
wheezing, coughing, and shortness of breath. Asthma 
is a multifactorial disease process with genetic, 
allergic, environmental, infectious, emotional, and 
nutritional components. The underlying 
pathophysiology of asthma is airway inflammation. In 
this section it was explained about types, etiological 
factors, signs and symptoms, differential diagnosis, 
treatments and lab investigations.  
About the drugs used for treatment of 
Tamaka Swasa. Bharangyadi Choorna contains of two 
drugs Bharangi and Shunti, Vyaghri Choorna contains 
of three drugs Kantakari, Dhatri and Jeeraka. All the 
drugs are having Kapha Vatashamaka properties 
because of its Rasa, Guna, Veerya and Vipaka. Only 
Amalaki have Tridoshahara property. Anti-
inflammatory and anti-asthmatic properties are the 
other benefits of these drugs. 
DISCUSSION ON OBSERVATION 
Age: Out of 60 patients of Tamakaswasa maximum 
number of patients around 30% were between 38-47 
years of age group. Group wise division 30% in group 
A and 26.7% in group B. This shows that 
Tamakaswasa is more prevalent in younger adults 
around age 35. 
Gender: However, the link between gender and 
incidence of Asthma has not been established. In the 
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present study out of 60 patients 55% were males. It 
may be high level of exposure to etiological factors 
like dust, smoke and habits like smoking etc. 
Religion: Out of 60 patients taken for study 55% of 
patients are Hindus, 35% were Muslims and 10% 
were Christians. The high incidence of illness in 
Hindus in this study cannot predict because it may be 
due to the small sample size and availability of 
patients in this particular area. 
Occupation: In this study of 60 patients most of 
them are house wives and workers. This may be due 
to exposure to dust, irregular dietary habits which 
may cause respiratory disorders. 
Socio-economic status: Out of 60 patients 53.3%of 
patients belong to middle class. This might be due to 
higher level of the exposure to different kinds of 
allergens in the middle class due to their competitive 
environment and low health care maintenance in 
middle class people. 
Marital status: Out of 60 patients 76.7% were 
married. That could be because of the inclusion of 
patients between age 16-60 years includes the 
maximum of marital age. 
Sleep: In this study out of 60 patients, majority of 
patients had disturbed sleep 50%. Whereas 28.8% 
patients had irregular sleep, 13.3% patients had 
delayed sleep and 6.7% had sounded sleep. Day sleep 
is the main reason that aggravates Swasa. 
Pet keeping: Out of 60 patients, maximum patients 
(81.7%) are not keeping pets. But 18.3% patient 
were keeping pets at home, pet dander may be one of 
the cause for Asthma. 
Habit: Out of 60 patients majority of the patients 
don’t have any type of addiction or habit. But some 
patients had the habit of smoking beedi, cigarette and 
some are addicted to tea/ coffee and 5% are using 
snuff. These habit may be one of the cause for 
Asthma. 
Diet: Among 60 patients, maximum numbers of 
patients i.e. 75% were used to take mixed diet. Non 
vegetarian foods mixed with Vyanjakas and its 
Gurutva in getting digested, lead to the formation of 
Ama and Srotho-Abhishyanda which in turn causes 
vitiation of Tridosha in Amashaya. 
DISCUSSION ON RESULT 
Effect of treatment on Swasakrichratha 
The symptoms Swasakrichratha was reduced 
and showed highly significant result at P<0.01 before 
treatment. It shows symptom reduced to 38.89% 
after treatment and after follow up it became 53.70% 
improvement in Group A. In Group B after treatment 
symptom reduced to 20.45% and after follow up with 
38.64% improvement. While comparing both the 
groups there is Statistically Significant result at 
P<0.05 was found. 
Breathlessness (Swasakrichratha) is due to 
broncho-constriction (Srotosanga) of the airway due 
to inflammatory causes like increased secretion of 
bronchial mucous gland and epithelial secretions etc. 
So this study shows reduction and clearance in the 
obstruction to the passage of Pranavayu by clearing 
the morbid Kapha which results in reduction in 
Pranavilomata by the treatment. 
Effect of Treatment on Peenasa 
The symptoms Peenasa was reduced and 
showed highly significant result at P<0.01 before 
treatment. It showed reduction of 47.37% relief of 
symptom after treatment and after follow up it 
symptom reduced 84.21% in group A. in group B it 
showed reduction of 23.53% relief of symptom after 
treatment and 58.82% improvement after follow up. 
While comparing both the groups there is 
Statistically Significant result at P<0.05 was found.  
Effect of treatment on Kasa 
The symptom Kasa was reduced and shoes 
highly significant result at P<0.01 in the period of 
after treatment 42.42% improvement and after 
follow up 69.70% improvement was found in group 
A. In group B after treatment symptom reduced to 
16.67% and after follow up it showed an 
improvement of 47.22%. While comparing both the 
groups there is Statistically Significant result at 
P<0.05 was found.  
Kasa is an effort to expel the Kapha. 
(Malaroopa) secreted in the Pranavaha Srotas. So on 
administration of medicine, there would have been in 
acting in liquefaction of the sputum, and then only 
the diminishing of the cough is possible. 
Effect of treatment on Ghurghuraka 
The symptom Ghurghuraka was reduced and 
showed highly significant result at P<0.01 in the 
period of after treatment it showed 37.50% and after 
follow up it showed 62.50% improvement in group A. 
In group B it showed that after treatment symptom 
reduced 9.80% and after follow up symptom 
Ghurghuraka reduced to 45.10%. While comparing 
both the groups there is Statistically Significant result 
at P<0.05 was found.  
Wheeze (Ghurghuraka) is generated by 
vibration in the wall of an airway on the point of 
closer due to smooth muscle contraction. Drugs helps 
for the Kapha Vilayana and thus it helps for the 
reduction in the Sroto Sanga. 
Effect of treatment on Krichrabhashana 
The symptom Krichrabhashana was reduced 
and showed highly significant result at P<0.01 in the 
period of after treatment it showed 23.53% and after 
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follow up it showed 70.59% improvement in group A. 
In group B it showed that after treatment symptom 
reduced 24% and after follow up symptom reduced 
to 60%. While comparing both the groups there is 
Statistically Significant result at P<0.05 was found.  
Effect of treatment on Shushkasya 
The symptom Shushkasya was reduced and 
showed highly significant result at P<0.01 in the 
period of after treatment it showed 56% and after 
follow up it showed 76% improvement in group A. In 
group B it showed that after treatment symptom 
reduced 44.44% and after follow up symptom 
reduced to 38.89%. While comparing both the groups 
there is Statistically Significant result at P<0.05 was 
found.  
Effect of treatment in PEFR 
The objective criteria PEFR was reduced and 
shows highly significant result at P<0.01 in the 
period of after treatment it showed 62.03% and after 
follow up it showed 92.41% improvement in group A. 
In group B it showed that after treatment 12.50% 
improvement and after follow up it showed 
improvement of 27.08%. While comparing both the 
groups there is Statistically Significant result at 
P<0.05 was found.  
This may be due to the Kapha Vilayana 
property of the drug and enhances the normal Gati of 
Vata. It shows significant reduction in the airway 
obstruction. 
Discussion on Mode of Action of Drug  
Probable Mode of Action of Bharangyadi Choorna 
The mode of action of drugs in Bharangyadi 
Choorna i.e., Bharangi and Shunti is due to its Vata 
Kapha Shamaka property. Especially Bharangi has 
Kaphaghna property which directly acts on the 
causative Dosha. It pacifies the vitiated Kapha Dosha 
which is dominant in the pathogenesis of 
Tamakaswasa as well as depletes the excessively 
produced Rasa Mala Kapha. Thus it is known to act 
against the Kaphapradhana pathogenesis of Tamaka 
Swasa but because of Guru, Snigdha Guna and 
Madhura Vipaka Shunthi is also effective on 
Vatapradhana pathogenesis. Both drugs are Deepana, 
Pachana and Shunthi is Amnashaka (Rasagata 
Kaphanashaka) so act on Agni and alleviate the Ama. 
This would also clear up the Rasa Dhatu Dushti, and 
excessive production of Mala Kapha. These drugs 
help at the level of Agni in Samprapti Vighatana. 
Shunthi has Sroto shodhana property it cleans 
the various channels of Pranavaha Srotas which leads 
to Anuloma Gati of Vata. In this manner these 
Srotoshodhaka drugs help in Samprapti Vighatana. 
Shunthi has Vatakapha Shamaka property 
and Bharngi has Kaphaghna property in this way it 
helps in the Samprapti Vighatana at the level of 
Pratiloma Vata Dosha and removes obstruction. Both 
drugs also have Shwasahara, Kasahara action 
mentioned in various Ayurveda texts. 
CONCLUSION 
After the study regarding Tamakaswasa and 
its treatment, the following conclusions are explained 
below. 
It is observed that diet pattern, increasing 
stress and pollution are the main causative factors for 
Tamaka Swasa. The present study shows the 
incidence of the disease Tamakaswasa is found more 
in males than females. Majority of the patients had 
complaints viz., Ghurghuraka, Swasakrichratha, 
Peenasa, Kasa, Shushkasya and Krichrabhasana. The 
disease Tamakaswasa can be equated with Bronchial 
Asthma in modern parlance due to its similarity in 
presentation. 
Two Choorna Yogas– Bharangyadi Choorna 
and Vyghri Choorna were taken as the trial drug and 
control drug respectively. Effect of therapy on each 
and every sign and symptom were considered and 
critically analyzed. The results thus obtained were 
subjected to analytical statistical techniques to 
compare both types of treatments. 
In this study Bharangi and Shunti are having 
all the properties required to break down the 
Samprapthi of Tamaka Swasa. Both Bharangiyadi 
Choorna and Vyaghri Choorna have the properties of 
kaphavata hara, Agni Deepana Pachana, Anulomana, 
Srotoshodhana, anti-asthamatic and anti 
inflammatory property. But Bharangyadi Choorna 
had got better improvement (75.64%) than Vyaghri 
Choorna (46.23%). 
When comparing both groups Bharangyadi 
Choorna and Vyghri Choorna both have significant 
effects on symptoms of Tamaka Swasa. Bharangyadi 
Choorna shows better improvement of the 
symptoms– Swasakrichratha, Peenasa, Kasa, 
Ghurghuraka, Krichrabhasana, Shushkasya and in the 
objective parameter– PEFR than Vyaghri Choorna. 
Hence H2 holds good and proved. 
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